InsightfulValue
← Home

Bristol Myers Squibb
Bristol Myers Squibb

Pharma / Pharma


πŸ”§ Tools

βœ… Due Diligence
🧩 Revenue Segmentation by Product

Switch to Location
Fiscal year Segment Value
2024 Sotyktu 246M
2024 Breyanzi 747M
2024 Sprycel 1.29B
2024 Eliquis 13.33B
2024 Pomalyst/Imnovid 3.55B
2024 Zeposia 566M
2024 Augtyro 38M
2024 Abecma 406M
2024 Reblozyl 1.77B
Bristol Myers Squibb

πŸ’° Explore more revenue segmentation data for Bristol Myers Squibb!

Sign up for free or log in

✍️ Sign up to get "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" for free

© 2024 - 2025 InsightfulValue.com. All rights reserved. Newsletter
Legal